Poster Abstract Session:
249. Non-Tuberculous Mycobacteria - Epidemiology and Management
Saturday, October 7, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD


Presentations:
Extrapulmonary nontuberculous mycobacterial infections in Southern Arizona
Catalin Florita, MD; Tirdad Zangeneh, DO; Anca Georgescu, MD
Tuberculosis and Leprosy Co-Infection: A Perspective on Diagnosis and Treatment
Dustin Kilpatrick, DO; Rahul Sampath, MD; Allison Jones, DO; Sarah Movaghar, DO; Rachel Kelly, DO; Donald Costic, MD
The epidemiology of non-tuberculous mycobacteria (NTM) from non-pulmonary sites over 4 years in Nebraska
Maureen Tierney, MD, MSc; Caitlin Pedati, MD, MPH; Alison Keyser, MPH; Tom Safranek, MD
Septic Olecranon Bursitis caused by Non-tuberculous Mycobacteria, the Mayo Clinic Experience
Anil Jagtiani, M.D.; Aaron Tande, M.D.; Mark Morrey, M.D.; Abinash Virk, MD, FIDSA
Patterns of Fluoroquinolone Prescribing at a Tuberculosis Hospital  
Quratulain Kizilbash, MD, MPH; Vanessa Meyer, PharmD; Chizoba Anozie, PharmD; Adriana Vasquez, MD
Posters
  • Poster_IDSA_2.pdf (1.0 MB)
  • Disseminated Mycobacterium genavense in the immunocompromised: a case series at Mayo Clinic Rochester
    Maryam Mahmood, MD; Saira Ajmal, MD; Jasmine R. Marcelin, MD; Omar Abu Saleh, MD
    Posters
  • ID wk M gen.pdf (601.4 kB)
  • Mycobacterium gordonae isolation in Oregon, 2005-2012
    Cara Varley, MD, MPH; Emily Henkle, PhD, MPH; Kevin L. Winthrop, MD, MPH
    Posters
  • M.gordonae_9_25_17.pdf (202.5 kB)
  • Clofazimine for Rapidly Growing Mycobacterial Infections
    George B. Carey, Medical Student; Deborah Kim, RPh; Harvey Rubin, MD, PhD; Denis Hadjiliadis, MD, MHS; John Hansen-Flaschen, MD; Daniel Dorgan, MD; Sarah Longworth, MD; Janet Hines, MD; Marissa Wilck, MD; Emily Blumberg, MD; Blair C. Weikert, MD; Anne Norris, MD; Pablo Tebas, MD, FIDSA; Keith Hamilton, MD
    Healthcare resource utilization and costs following diagnosis of nontuberculous mycobacterial lung disease in the US
    Theodore Marras, MD; Mehdi Mirsaeidi, MD, MPH; Engels Chou, MS; Gina Eagle, MD; Raymond Zhang, MBA; Ping Wang, PhD; Quanwu Zhang, PhD
    Major risk factors for leprosy in a non-endemic area of the United States
    Jellyana Peraza, MD; Andrew Mekaiel, MD; Manuel Castro-Borobio, MD; Beata Casanas, DO; Sadaf Aslam, MD
    Rate of all-cause hospitalization at year 2 between treatment groups following diagnosis of nontuberculous mycobacterial lung disease in the US
    Theodore Marras, MD; Mehdi Mirsaeidi, MD, MPH; Engels Chou, MS; Gina Eagle, MD; Raymond Zhang, MBA; Ping Wang, PhD; Quanwu Zhang, PhD
    Reduction in Nontuberculous Mycobacteria at a Tuberculosis Hospital Following a Quality Assurance Intervention
    Quratulain Kizilbash, MD, MPH; Kenneth Jost, PhD; Lisa Armitige, MD, PhD; David E. Griffith, MD; Denise Dunbar, PhD; Barbara Seaworth, MD, FIDSA
    Posters
  • Poster_IDSA_1.pdf (1.4 MB)
  • Evaluation of Ceftaroline-Avibactam Activity in vitro and ex vivo Against Mycobacterium abscessus Complex
    Ruchi Pandey, PhD; Liang Chen, PhD; Elena Shashkina, PhD; Claudia Manca, PhD; Robert A. Bonomo, MD; Stephen G Jenkins, PhD; Barry N. Kreiswirth, PhD
    Clofazimine for Treatment of Mycobacterium abscessus Infections in Children
    Felice C. Adler-Shohet, MD; Jasjit Singh, MD; Delma Nieves, MD; Negar Ashouri, MD; M. Tuan Tran, PharmD; Cathy Flores, RN, CCRC; Antonio Arrieta, MD, FIDSA
    Nontuberculous Mycobacteria Isolates at a Cancer Center: A 5-year Experience at H. Lee Moffitt Cancer Center in Tampa, Florida
    Anteneh Addisu, MD, PhD; Muhammad Chughtai, MD; Louise Gutierrez, MD; John Greene, MD, FACP
    Treatment Regimens Prescribed for Mycobacterium avium complex Infections Diagnosed in Hospitalized Patients throughout the United States, 2008-2013
    Emily Ricotta, PhD, ScM; D. Rebecca Prevots, PhD, MPH; Kenneth Olivier, MD, MPH; Jennifer Adjemian, PhD
    Posters
  • IDSA_Ricotta_2017_Final.pdf (579.8 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.